title: Epidermal growth factor receptor in glioma: signal transduction, neuropathology, imaging, and radioresistance.
abstract: Aberrant epidermal growth factor receptor (EGFR) signaling is common in cancer. Increased expression of wild type and mutant EGFR is a widespread feature of diverse types of cancer. EGFR signaling in cancer has been the focus of intense investigation for decades primarily for two reasons. First, aberrant EGFR signaling is likely to play an important role in the pathogenesis of cancer, and therefore, the mechanisms of EGFR-mediated oncogenic signaling are of interest. Second, the EGFR signaling system is an attractive target for therapeutic intervention. EGFR gene amplification and overexpression are a particularly striking feature of glioblastoma (GBM), observed in approximately 40% of tumors. GBM is the most common primary malignant tumor of the central nervous system in adults. In approximately 50% of tumors with EGFR amplification, a specific EGFR mutant (EGFRvIII, also known as EGFR type III, de2-7, Delta EGFR) can be detected. This mutant is highly oncogenic and is generated from a deletion of exons 2 to 7 of the EGFR gene, which results in an in-frame deletion of 267 amino acids from the extracellular domain of the receptor. EGFRvIII is unable to bind ligand, and it signals constitutively. Although EGFRvIII has the same signaling domain as the wild type receptor, it seems to generate a distinct set of downstream signals that may contribute to an increased tumorigenicity. In this review, we discuss recent progress in key aspects of EGFR signaling in GBM, focusing on neuropathology, signal transduction, imaging of the EGFR, and the role of the EGFR in mediating resistance to radiation therapy in GBM.
authors.affiliation: Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
authors.forename: Kimmo J
authors.initials: KJ
authors.lastname: Hatanpaa
authors.forename: Sandeep
authors.initials: S
authors.lastname: Burma
authors.forename: Dawen
authors.initials: D
authors.lastname: Zhao
authors.forename: Amyn A
authors.initials: AA
authors.lastname: Habib
mesh_terms: D000328:Adult; D001932:Brain Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000235:genetics / Q000532:radiotherapy; D003952:Diagnostic Imaging / Q000379:methods*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics / Q000502:physiology*; D005910:Glioma / Q000175:diagnosis / Q000209:etiology / Q000235:genetics / Q000532:radiotherapy; D006801:Humans; D008954:Models, Biological; D058990:Molecular Targeted Therapy / Q000379:methods; D050505:Mutant Proteins / Q000235:genetics / Q000502:physiology; D011836:Radiation Tolerance / Q000235:genetics* / Q000502:physiology; D019275:Radiopharmaceuticals / Q000627:therapeutic use; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology
chemical_list: D050505:Mutant Proteins; D019275:Radiopharmaceuticals; D066246:ErbB Receptors
references.citation: Mol Cell Biol. 2003 Mar;23(6):2068-82
references.pmid: 12612079
references.citation: Brain. 2007 Oct;130(Pt 10):2596-606
references.pmid: 17785346
references.citation: Curr Opin Cell Biol. 1999 Aug;11(4):483-8
references.pmid: 10449328
references.citation: Exp Cell Res. 2003 Mar 10;284(1):78-88
references.pmid: 12648467
references.citation: Cancer Res. 2006 Nov 15;66(22):10815-23
references.pmid: 17090523
references.citation: Eur J Nucl Med Mol Imaging. 2007 Jun;34(6):850-8
references.pmid: 17262214
references.citation: Radiat Oncol Investig. 1997;5(4):180-6
references.pmid: 9327497
references.citation: Am J Pathol. 2000 Feb;156(2):425-32
references.pmid: 10666371
references.citation: Cancer Res. 2004 Nov 15;64(22):8292-8
references.pmid: 15548697
references.citation: Clin Cancer Res. 2005 Dec 15;11(24 Pt 1):8600-5
references.pmid: 16361543
references.citation: Cancer Res. 2001 Feb 1;61(3):1122-8
references.pmid: 11221842
references.citation: Cancer Cell. 2004 Nov;6(5):447-58
references.pmid: 15542429
references.citation: J Neuropathol Exp Neurol. 1998 Jul;57(7):684-9
references.pmid: 9690672
references.citation: Mol Cancer Ther. 2006 Feb;5(2):209-18
references.pmid: 16505093
references.citation: Acta Neuropathol. 1998 Oct;96(4):322-8
references.pmid: 9796995
references.citation: Cancer Res. 2007 Apr 15;67(8):3809-17
references.pmid: 17440095
references.citation: Oncogene. 1989 Jul;4(7):831-8
references.pmid: 2755700
references.citation: J Neurooncol. 2002 Jul;58(3):217-36
references.pmid: 12187957
references.citation: Proc Natl Acad Sci U S A. 2003 May 27;100(11):6505-10
references.pmid: 12734385
references.citation: DNA Repair (Amst). 2006 Sep 8;5(9-10):1042-8
references.pmid: 16822724
references.citation: Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7727-31
references.pmid: 8052651
references.citation: Cancer Res. 1996 Nov 1;56(21):5079-86
references.pmid: 8895767
references.citation: Cancer Res. 2005 Oct 1;65(19):8679-89
references.pmid: 16204036
references.citation: Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):186-208
references.pmid: 17846765
references.citation: Cancer. 1991 May 1;67(9):2342-9
references.pmid: 1849447
references.citation: J Neurosurg. 2009 Aug;111(2):211-8
references.pmid: 19301967
references.citation: Proc Natl Acad Sci U S A. 2006 Mar 7;103(10):3775-80
references.pmid: 16537454
references.citation: Science. 2009 May 8;324(5928):804-7
references.pmid: 19423828
references.citation: Int J Radiat Biol. 2007 Nov-Dec;83(11-12):781-91
references.pmid: 18058366
references.citation: Nat Rev Cancer. 2006 Nov;6(11):876-85
references.pmid: 17036041
references.citation: Cancer Res. 2007 Jun 1;67(11):5267-74
references.pmid: 17545606
references.citation: Clin Cancer Res. 2004 May 1;10(9):3216-24
references.pmid: 15131063
references.citation: Clin Cancer Res. 2008 Jan 1;14(1):199-208
references.pmid: 18172271
references.citation: PLoS One. 2009 Aug 06;4(8):e6539
references.pmid: 19657384
references.citation: Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3):966-71
references.pmid: 14967457
references.citation: Clin Cancer Res. 2004 Oct 1;10(19):6476-86
references.pmid: 15475435
references.citation: Arch Pathol Lab Med. 2005 May;129(5):624-31
references.pmid: 15859633
references.citation: J Biol Chem. 2004 Aug 6;279(32):33085-92
references.pmid: 15159408
references.citation: J Neuropathol Exp Neurol. 2004 Jul;63(7):700-7
references.pmid: 15290895
references.citation: Mol Cancer Res. 2005 Oct;3(10):541-51
references.pmid: 16254188
references.citation: Cancer Res. 1991 Apr 15;51(8):2164-72
references.pmid: 2009534
references.citation: Cancer Res. 2009 May 15;69(10):4252-9
references.pmid: 19435898
references.citation: Lab Invest. 1999 Feb;79(2):123-9
references.pmid: 10068201
references.citation: J Neuropathol Exp Neurol. 2001 Sep;60(9):863-71
references.pmid: 11556543
references.citation: Oncogene. 2003 Aug 28;22(36):5545-53
references.pmid: 12944901
references.citation: Cancer Res. 2002 Jun 15;62(12):3335-9
references.pmid: 12067969
references.citation: Oncogene. 2000 Dec 27;19(56):6550-65
references.pmid: 11426640
references.citation: Biochim Biophys Acta. 1996 Nov 8;1314(1-2):147-56
references.pmid: 8972728
references.citation: Neuro Oncol. 2009 Dec;11(6):833-41
references.pmid: 19332771
references.citation: Proc Natl Acad Sci U S A. 1998 May 12;95(10):5724-9
references.pmid: 9576951
references.citation: Oncogene. 2002 Aug 1;21(33):5038-46
references.pmid: 12140754
references.citation: Cancer Res. 2002 Dec 15;62(24):7350-6
references.pmid: 12499279
references.citation: Oncogene. 2004 Aug 12;23(36):6095-104
references.pmid: 15221011
references.citation: J Biol Chem. 2007 Jul 20;282(29):21206-12
references.pmid: 17513297
references.citation: Brain Pathol. 2004 Apr;14(2):131-6
references.pmid: 15193025
references.citation: Arch Pathol Lab Med. 2007 Oct;131(10):1585-90
references.pmid: 17922598
references.citation: Neoplasia. 2005 Aug;7(8):717-22
references.pmid: 16207473
references.citation: Acta Neuropathol. 2007 Aug;114(2):97-109
references.pmid: 17618441
references.citation: Radiother Oncol. 2005 Aug;76(2):157-61
references.pmid: 16024112
references.citation: Oncogene. 2004 Feb 19;23(7):1448-56
references.pmid: 14973554
references.citation: Cancer Cell. 2007 Jan;11(1):83-95
references.pmid: 17222792
references.citation: Nat Clin Pract Oncol. 2006 Apr;3(4):170-1
references.pmid: 16596125
references.citation: N Engl J Med. 2005 Nov 10;353(19):1997-9
references.pmid: 16282174
references.citation: Biochem J. 1997 Jun 15;324 ( Pt 3):855-61
references.pmid: 9210410
references.citation: FEBS Lett. 2001 Feb 16;490(3):142-52
references.pmid: 11223029
references.citation: Ann Oncol. 2009 Feb;20(2):213-26
references.pmid: 18842614
references.citation: Clin Cancer Res. 2003 Sep 15;9(11):4247-54
references.pmid: 14519652
references.citation: Clin Cancer Res. 1999 Oct;5(10):2884-90
references.pmid: 10537357
references.citation: Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2965-9
references.pmid: 1557402
references.citation: Neuro Oncol. 2005 Apr;7(2):122-33
references.pmid: 15831231
references.citation: DNA Repair (Amst). 2004 Aug-Sep;3(8-9):909-18
references.pmid: 15279776
references.citation: Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):228-33
references.pmid: 14734474
references.citation: N Engl J Med. 2009 Sep 3;361(10):958-67
references.pmid: 19692684
references.citation: J Biol Chem. 1997 Jan 31;272(5):2927-35
references.pmid: 9006938
references.citation: Cancer. 2004 Nov 15;101(10):2318-26
references.pmid: 15470710
references.citation: Am J Pathol. 2007 May;170(5):1445-53
references.pmid: 17456751
references.citation: Int J Cancer. 1998 Feb 9;75(4):626-34
references.pmid: 9466667
references.citation: Mol Cancer Ther. 2008 Jul;7(7):1772-81
references.pmid: 18644989
references.citation: Biochim Biophys Acta. 2001 Feb 5;1538(1):1-9
references.pmid: 11341977
references.citation: J Biol Chem. 1998 Jan 16;273(3):1568-73
references.pmid: 9430697
references.citation: J Neuropathol Exp Neurol. 2001 Nov;60(11):1099-104
references.pmid: 11706939
references.citation: J Neurooncol. 2003 Jul;63(3):247-56
references.pmid: 12892230
references.citation: Cancer Res. 2003 Jan 15;63(2):413-6
references.pmid: 12543796
references.citation: Cancer Lett. 2006 Nov 18;243(2):145-59
references.pmid: 16530325
references.citation: J Cell Biol. 1988 Aug;107(2):801-10
references.pmid: 3262110
references.citation: Cancer Res. 2006 Jan 15;66(2):867-74
references.pmid: 16424019
references.citation: Genes Dev. 1998 Dec 1;12(23):3675-85
references.pmid: 9851974
references.citation: Oncogene. 1997 Sep 4;15(10):1191-7
references.pmid: 9294612
references.citation: Cancer Res. 2002 Aug 15;62(16):4671-7
references.pmid: 12183424
references.citation: Oncogene. 2005 Nov 14;24(50):7455-64
references.pmid: 16288292
references.citation: Cancer Res. 1987 Jul 15;47(14):3847-50
references.pmid: 3594441
references.citation: J Biol Chem. 1990 May 15;265(14):7709-12
references.pmid: 2186024
references.citation: Mol Cancer Res. 2009 Jul;7(7):1000-12
references.pmid: 19584260
references.citation: Cancer Res. 2009 Oct 1;69(19):7548-56
references.pmid: 19773446
references.citation: Science. 2004 Jun 4;304(5676):1497-500
references.pmid: 15118125
references.citation: Cancer Res. 2006 Feb 15;66(4):2116-28
references.pmid: 16489012
references.citation: Lancet Oncol. 2006 May;7(5):359-60
references.pmid: 16648038
references.citation: Mol Cancer Res. 2005 Apr;3(4):237-49
references.pmid: 15831677
references.citation: JAMA. 2005 Feb 16;293(7):855-62
references.pmid: 15713776
references.citation: Cancer Biol Ther. 2009 Apr;8(8):730-8
references.pmid: 19252415
references.citation: Mol Cell Neurosci. 2003 Dec;24(4):1116-30
references.pmid: 14697673
references.citation: Small. 2009 Feb;5(2):235-43
references.pmid: 19089838
references.citation: Mol Imaging Biol. 2006 Sep-Oct;8(5):262-77
references.pmid: 16897320
references.citation: J Nucl Med. 2005 Nov;46(11):1881-8
references.pmid: 16269603
references.citation: J Biol Chem. 2005 Sep 2;280(35):31182-9
references.pmid: 16000298
references.citation: J Nucl Med. 2009 Feb;50(2):274-83
references.pmid: 19164241
references.citation: Brain Pathol. 2000 Apr;10(2):249-59
references.pmid: 10764044
references.citation: Nat Cell Biol. 2007 May;9(5):493-505
references.pmid: 17450133
references.citation: Cancer Res. 2003 Jun 1;63(11):2742-6
references.pmid: 12782577
references.citation: J Natl Cancer Inst. 2001 Aug 15;93(16):1246-56
references.pmid: 11504770
references.citation: J Biol Chem. 1990 Sep 15;265(26):15713-23
references.pmid: 1975591
references.citation: Mol Biol Cell. 1999 Aug;10(8):2493-506
references.pmid: 10436007
references.citation: Hum Reprod. 2005 Apr;20(4):852-63
references.pmid: 15705628
references.citation: Cancer Res. 2003 Oct 15;63(20):6962-70
references.pmid: 14583498
references.citation: J Biomed Opt. 2007 Mar-Apr;12(2):024017
references.pmid: 17477732
references.citation: J Neuropathol Exp Neurol. 2004 Mar;63(3):210-22
references.pmid: 15055445
references.citation: Oncogene. 1996 Jul 4;13(1):85-96
references.pmid: 8700557
references.citation: Cancer Cell. 2008 May;13(5):379-80
references.pmid: 18455120
references.citation: Curr Pharm Des. 2008;14(28):2983-98
references.pmid: 18991714
references.citation: Cancer Res. 2003 Nov 15;63(22):7870-5
references.pmid: 14633715
references.citation: Oncogene. 2002 Jun 6;21(25):4032-41
references.pmid: 12037685
references.citation: J Biol Chem. 1998 Jan 2;273(1):200-6
references.pmid: 9417065
references.citation: J Neurooncol. 1997 Dec;35(3):303-14
references.pmid: 9440027
references.citation: Oncogene. 1993 Apr;8(4):1017-22
references.pmid: 8455929
references.citation: J Clin Oncol. 2006 Dec 1;24(34):5419-26
references.pmid: 17135643
references.citation: Cancer Res. 2006 Oct 1;66(19):9601-8
references.pmid: 17018617
references.citation: Mol Cancer Res. 2003 Jan;1(3):219-33
references.pmid: 12556561
references.citation: Science. 1991 Nov 22;254(5035):1146-53
references.pmid: 1659742
references.citation: Cancer Res. 2002 Nov 15;62(22):6764-9
references.pmid: 12438278
references.citation: J Clin Oncol. 2008 Dec 1;26(34):5603-9
references.pmid: 18955445
references.citation: Carcinogenesis. 2005 Jul;26(7):1224-32
references.pmid: 15760917
references.citation: Cell Growth Differ. 1995 Oct;6(10):1251-9
references.pmid: 8845302
references.citation: J Neurosci. 2008 Jun 4;28(23):5870-8
references.pmid: 18524891
references.citation: Sci Signal. 2009 Sep 08;2(87):re6
references.pmid: 19738203
references.citation: Cancer Res. 2001 Mar 1;61(5):2301-6
references.pmid: 11280802
references.citation: N Engl J Med. 2004 May 20;350(21):2129-39
references.pmid: 15118073
references.citation: Proc Natl Acad Sci U S A. 2008 Jun 3;105(22):7785-90
references.pmid: 18505846
references.citation: N Engl J Med. 1980 Oct 9;303(15):878-80
references.pmid: 7412807
references.citation: N Engl J Med. 2005 Nov 10;353(19):2012-24
references.pmid: 16282176
references.citation: Br Med Bull. 1991 Jan;47(1):87-98
references.pmid: 1863851
references.citation: Brain Pathol. 1996 Jul;6(3):217-23; discussion 23-4
references.pmid: 8864278
references.citation: Clin Cancer Res. 2006 Dec 15;12(24):7261-70
references.pmid: 17189397
references.citation: Cancer Cell. 2009 Jul 7;16(1):9-20
references.pmid: 19573808
references.citation: Radiat Res. 1996 Jan;145(1):81-5
references.pmid: 8532841
references.citation: Oncogene. 2004 Jun 3;23(26):4594-602
references.pmid: 15077177
references.citation: Oncogene. 2006 Nov 2;25(52):6986-96
references.pmid: 16715132
references.citation: Neuro Oncol. 2009 Jun;11(3):274-80
references.pmid: 18981259
references.citation: Mol Cell. 2008 Apr 25;30(2):203-13
references.pmid: 18439899
references.citation: J Nucl Med. 2009 Feb;50(2):303-8
references.pmid: 19164239
references.citation: J Biol Chem. 1996 Oct 11;271(41):25639-45
references.pmid: 8810340
references.citation: Clin Cancer Res. 2005 Feb 15;11(4):1462-6
references.pmid: 15746047